Authors: CHAO Y CHAN WK BIRKHOFER MJ HU OYP WANG SS HUANG YS LIU M WHANGPENG J CHI KH LUI WY LEE SD

Citation: Y. Chao et al., PHASE-II AND PHARMACOKINETIC STUDY OF PACLITAXEL THERAPY FOR UNRESECTABLE HEPATOCELLULAR-CARCINOMA PATIENTS, British Journal of Cancer, 78(1), 1998, pp. 34-39

Authors: HUIZING MT VANWARMERDAM LJC ROSING H SCHAEFERS MCW LAI A HELMERHORST TJM VEENHOF CHN BIRKHOFER MJ RODENHUIS S BEIJNEN JH TENBOKKELHUININK WW

Citation: Mt. Huizing et al., PHASE-I AND PHARMACOLOGICAL STUDY OF THE COMBINATION PACLITAXEL AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY IN STAGE-III AND STAGE-IV OVARIAN-CANCER, Journal of clinical oncology, 15(5), 1997, pp. 1953-1964

Authors: SONNICHSEN DS SUMMERILL RS RAYMOND RH WEINER RS ABRAMS JR BIRKHOFER MJ

Citation: Ds. Sonnichsen et al., PHARMACOKINETIC (PK) MODELING OF BMS-188667 (CTLA4IG), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 104-104